Adjuvant Afatinib in Stage I-III NSCLC With EGFR Mutation
Clinical trial NCT01746251 · UNKNOWN
Trial details
- NCT number
- NCT01746251
- Sponsor
- Massachusetts General Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2020-11-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.